
Keywords: 6-MAM; 6-monoacetylmorphine; CNS; central nervous system; DMAA; dimethylamylamine; EtG; ethyglucuronide; ELISA; enzyme-linked immunosorbent assay; FDA; Food and Drug Administration; GC-MS; gas chromatography/mass spectrometry; LC-MS/MS; liquid chromatogra